Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BRIDGE Device for Post-operative Pain Control

NCT: NCT03265249 · TERMINATED

NCT IDNCT03265249
StatusTERMINATED
Start Date2018-02-12
Completion2020-04-03

Brief Summary

Auricular neurostimulation is a potential novel and non-invasive method of pain control following liver transplantation in a growing patient population with the probability of significant impact on economics and morbidity. The investigators propose a pilot study to investigate the effects of auricular neurostimulation in patients receiving a liver transplantation. The investigator will investigate the effects of auricular neurostimulation with this novel device and compare it to the current standard of care for pain management following liver transplantation.

Frequently Asked Questions

What is BRIDGE Device for Post-operative Pain Control?

BRIDGE Device for Post-operative Pain Control is a clinical trial registered under NCT03265249. Current status: TERMINATED.

What is the status of NCT03265249?

The current status of NCT03265249 (BRIDGE Device for Post-operative Pain Control) is: TERMINATED.

When did BRIDGE Device for Post-operative Pain Control start?

BRIDGE Device for Post-operative Pain Control started on 2018-02-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.